Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

ADMA Biologics, Inc. (ADMA)

Biological Products, (no Disgnostic Substances)

https://www.admabiologics.com

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.

C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17
RAMSEY, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/17/2013

Market Cap

4,075,456,255

Shares Outstanding

225,970,000

Weighted SO

225,967,668

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

ATRA --.--%

FATE --.--%

SANA --.--%

CRBU --.--%

RCUS --.--%

TFFP --.--%

INMB --.--%

ANEB --.--%

ABCM --.--%

Beta

0.5460

Last Div

0.0000

Range

3.06-17.87

Chg

-0.1050

Avg Vol

3540658

Mkt Cap

4075456255

Exch

NASDAQ

Country

US

Phone

201 478 5552

DCF Diff

6.1999

DCF

-0.0399

Div Yield

0.0000

P/S

12.3407

EV Multiple

44.5949

P/FV

21.5852

Div Yield %

0.0000

P/E

116.8150

PEG

1.6743

Payout

0.0000

Current Ratio

6.8744

Quick Ratio

2.8042

Cash Ratio

1.9975

DSO

33.2822

DIO

367.7472

Op Cycle

401.0294

DPO

28.9989

CCC

372.0305

Gross Margin

0.4596

Op Margin

0.2542

Pretax Margin

0.1186

Net Margin

0.1053

Eff Tax Rate

0.2715

ROA

0.0924

ROE

0.2214

ROCE

0.2527

NI/EBT

0.8881

EBT/EBIT

0.4667

EBIT/Rev

0.2542

Debt Ratio

0.3513

D/E

0.7023

LT Debt/Cap

0.4104

Total Debt/Cap

0.4125

Int Coverage

6.6628

CF/Debt

0.5522

Equity Multi

1.9993

Rec Turnover

10.9668

Pay Turnover

12.5867

Inv Turnover

0.9925

FA Turnover

5.2025

Asset Turnover

0.8774

OCF/Share

0.3141

FCF/Share

0.2845

Cash/Share

0.3797

OCF/Sales

0.2211

FCF/OCF

0.9056

CF Coverage

0.5522

ST Coverage

63.9308

CapEx Coverage

10.5952

Div&CapEx Cov

10.5952

P/BV

21.5852

P/B

21.5852

P/S

12.3407

P/E

116.8150

P/FCF

61.6389

P/OCF

55.6619

P/CF

55.6619

PEG

1.6743

P/S

12.3407

EV Multiple

44.5949

P/FV

21.5852

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jul 31, 21:45 Adma Biologics (ADMA) Rises But Trails Market: What Investors Should Know Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Dec 29, 12:51 Acadia's (ACAD) Nuplazid Sales Drive Growth Amid Competition Zacks Investment Research Dec 26, 10:10 Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag Zacks Investment Research Dec 26, 09:30 Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? Zacks Investment Research Dec 25, 09:55 Should You Buy Adma Biologics (ADMA) After Golden Cross? Zacks Investment Research Dec 25, 09:55 Should You Buy Adma Biologics (ADMA) After Golden Cross? Zacks Investment Research Dec 25, 09:55 Should You Buy Adma Biologics (ADMA) After Golden Cross? The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday The Motley Fool Nov 17, 18:29 Why Adma Biologics Stock Crushed the Market on Friday

Revenue Product Segmentation